JP5624322B2 - 生体内電気化学的分析対象物感知を伴った液体供給 - Google Patents
生体内電気化学的分析対象物感知を伴った液体供給 Download PDFInfo
- Publication number
- JP5624322B2 JP5624322B2 JP2009542394A JP2009542394A JP5624322B2 JP 5624322 B2 JP5624322 B2 JP 5624322B2 JP 2009542394 A JP2009542394 A JP 2009542394A JP 2009542394 A JP2009542394 A JP 2009542394A JP 5624322 B2 JP5624322 B2 JP 5624322B2
- Authority
- JP
- Japan
- Prior art keywords
- cannula
- electrode
- processor
- analytes
- sensing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007788 liquid Substances 0.000 title claims description 39
- 239000012491 analyte Substances 0.000 title description 50
- 238000001727 in vivo Methods 0.000 title description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 47
- 239000008103 glucose Substances 0.000 claims description 47
- 238000003780 insertion Methods 0.000 claims description 40
- 230000037431 insertion Effects 0.000 claims description 40
- 238000007920 subcutaneous administration Methods 0.000 claims description 39
- 239000012530 fluid Substances 0.000 claims description 27
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 24
- 239000008280 blood Substances 0.000 claims description 20
- 210000004369 blood Anatomy 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- 238000011282 treatment Methods 0.000 claims description 19
- 230000001225 therapeutic effect Effects 0.000 claims description 17
- 102000004877 Insulin Human genes 0.000 claims description 14
- 108090001061 Insulin Proteins 0.000 claims description 13
- 229940125396 insulin Drugs 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 8
- 238000004159 blood analysis Methods 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 238000010586 diagram Methods 0.000 description 30
- 241001631457 Cannula Species 0.000 description 14
- 230000006870 function Effects 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 238000012544 monitoring process Methods 0.000 description 9
- 230000000149 penetrating effect Effects 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 210000003722 extracellular fluid Anatomy 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 239000012528 membrane Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000004891 communication Methods 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000011241 protective layer Substances 0.000 description 4
- 108010015776 Glucose oxidase Proteins 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940116332 glucose oxidase Drugs 0.000 description 3
- 235000019420 glucose oxidase Nutrition 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000003487 electrochemical reaction Methods 0.000 description 2
- 238000007772 electroless plating Methods 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 200000000007 Arterial disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000004082 amperometric method Methods 0.000 description 1
- 238000003928 amperometric titration Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 238000006056 electrooxidation reaction Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000003918 potentiometric titration Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M2005/14268—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body with a reusable and a disposable component
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Vascular Medicine (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Surgery (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87694506P | 2006-12-22 | 2006-12-22 | |
| PCT/IL2007/001579 WO2008078319A1 (en) | 2006-12-22 | 2007-12-20 | Fluid delivery with in vivo electrochemical analyte sensing |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011507556A JP2011507556A (ja) | 2011-03-10 |
| JP2011507556A5 JP2011507556A5 (enExample) | 2011-04-21 |
| JP5624322B2 true JP5624322B2 (ja) | 2014-11-12 |
Family
ID=39247973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009542394A Expired - Fee Related JP5624322B2 (ja) | 2006-12-22 | 2007-12-20 | 生体内電気化学的分析対象物感知を伴った液体供給 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9028409B2 (enExample) |
| EP (2) | EP2124726A1 (enExample) |
| JP (1) | JP5624322B2 (enExample) |
| CN (2) | CN101563022B (enExample) |
| AU (1) | AU2007337685A1 (enExample) |
| WO (1) | WO2008078319A1 (enExample) |
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
| EP2121076B1 (de) | 2006-12-29 | 2017-04-05 | F. Hoffmann-La Roche AG | Extrakorporal tragbare infusionsvorrichtung |
| FI3375470T3 (fi) * | 2007-04-10 | 2024-03-20 | Hoffmann La Roche | Laitteisto ja menetelmä nesteen pumppaamiseen |
| EP1987761B1 (de) * | 2007-05-03 | 2019-10-23 | F. Hoffmann-La Roche AG | Schlauchförmiger Sensor zum Nachweis eines Analyten |
| US8002752B2 (en) | 2007-06-25 | 2011-08-23 | Medingo, Ltd. | Protector apparatus |
| EP2173408A1 (en) * | 2007-06-27 | 2010-04-14 | Medingo Ltd. | Tubing for fluid delivery device |
| DK2173407T3 (da) * | 2007-07-02 | 2020-04-27 | Hoffmann La Roche | Anordning til indgivelse af lægemiddel |
| EP4098177A1 (en) | 2007-10-09 | 2022-12-07 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
| US20100256593A1 (en) * | 2007-11-21 | 2010-10-07 | Ofer Yodfat | Analyte Monitoring and Fluid Dispensing System |
| US9199031B2 (en) * | 2007-12-26 | 2015-12-01 | Ofer Yodfat | Maintaining glycemic control during exercise |
| ES2680896T3 (es) * | 2007-12-26 | 2018-09-11 | F. Hoffmann-La Roche Ag | Sistema para el control glucémico |
| US8845613B2 (en) | 2008-01-28 | 2014-09-30 | Roche Diagnostics Operations, Inc. | Bolus dose determination for a therapeutic fluid dispensing system |
| WO2009125398A2 (en) | 2008-04-09 | 2009-10-15 | Medingo Ltd. | Systems, devices and methods for fluid delivery |
| EP2277123B1 (en) | 2008-04-29 | 2019-08-07 | Roche Diabetes Care GmbH | A method for selecting bolus doses and bolus delivery patterns in a drug delivery device |
| US20110118699A1 (en) * | 2008-04-29 | 2011-05-19 | Ofer Yodfat | Methods and Apparatuses for Selecting a Bolus Delivery Pattern in a Drug Delivery Device |
| EP2286361A2 (en) * | 2008-05-16 | 2011-02-23 | Medingo Ltd. | Device and method for alleviating postprandial hyperglycemia |
| US9138531B2 (en) * | 2008-05-29 | 2015-09-22 | Roche Diagnostics Operations, Inc. | Device, a system and a method for identification/authentication of parts of a medical device |
| US8632497B2 (en) * | 2008-10-09 | 2014-01-21 | Roche Diagnostics Operations Inc. | Skin securable drug delivery device with a shock absorbing protective shield |
| US9566383B2 (en) | 2008-10-16 | 2017-02-14 | Roche Diabetes Care, Inc. | Method and system for adaptive communication transmission |
| EP2379133A1 (en) | 2008-11-11 | 2011-10-26 | Medingo Ltd. | Modular fluid delivery device with quick-release /connect mechanism for drive screw |
| EP2391408B1 (en) | 2008-12-31 | 2018-01-17 | Roche Diabetes Care GmbH | Portable medical fluid delivery device with drive screw articulated with reservoir plunger |
| US9597451B2 (en) | 2009-02-13 | 2017-03-21 | Roche Diagnostic Operations, Inc. | Insulin delivery safety |
| WO2010140151A1 (en) | 2009-06-04 | 2010-12-09 | Medingo Ltd. | Device and method for adjusting basal delivery profile |
| EP2442843A4 (en) | 2009-06-14 | 2012-11-28 | Medingo Ltd | DEVICES AND METHODS FOR RECOGNIZING DYSFUNCTIONS IN A THERAPEUTIC DELIVERY DEVICE |
| US8734383B2 (en) | 2009-06-25 | 2014-05-27 | Roche Diagnostics Operations, Inc. | Method and device for improving glycemic control based on residual insulin |
| US8000763B2 (en) * | 2009-06-30 | 2011-08-16 | Abbott Diabetes Care Inc. | Integrated devices having extruded electrode structures and methods of using same |
| US8437827B2 (en) * | 2009-06-30 | 2013-05-07 | Abbott Diabetes Care Inc. | Extruded analyte sensors and methods of using same |
| DK2475356T3 (da) | 2009-09-08 | 2019-06-17 | Hoffmann La Roche | Anordninger, systemer og fremgangsmåder til justering af fluidtilførselsparametre |
| WO2011033509A1 (en) | 2009-09-18 | 2011-03-24 | Medingo Ltd. | Devices, systems and methods for quantifying bolus doses according to user parameters |
| DK2506914T3 (en) | 2009-11-30 | 2018-12-10 | Hoffmann La Roche | ANALYSIS MONITORING AND FLUID SUBMISSION SYSTEM |
| WO2011089600A1 (en) | 2010-01-20 | 2011-07-28 | Medingo Ltd. | A method and device for improving glycemic control |
| PT2563450T (pt) | 2010-04-28 | 2017-08-28 | Kimberly Clark Co | Dispositivo para entrega de medicação para a artrite reumatóide |
| RU2585138C2 (ru) | 2010-04-28 | 2016-05-27 | Кимберли-Кларк Ворлдвайд, Инк. | Медицинские устройства для доставки кирнк |
| US10245421B2 (en) * | 2010-04-28 | 2019-04-02 | Sorrento Therapeutics, Inc. | Nanopatterned medical device with enhanced cellular interaction |
| CA2796965C (en) | 2010-04-28 | 2019-04-16 | Kimberly-Clark Worldwide, Inc. | Method for increasing permeability of an epithelial barrier |
| CN103261433A (zh) * | 2010-12-09 | 2013-08-21 | 雅培糖尿病护理股份有限公司 | 具有包括小型感测斑点的感测表面的分析物传感器 |
| ES2847578T3 (es) | 2011-04-15 | 2021-08-03 | Dexcom Inc | Calibración avanzada de sensor de analito y detección de errores |
| EP3542851B1 (en) * | 2011-10-27 | 2021-12-15 | Sorrento Therapeutics, Inc. | Implantable devices for delivery of bioactive agents |
| CN104039382B (zh) | 2011-10-27 | 2018-01-12 | 金伯利-克拉克环球有限公司 | 高粘度生物活性剂的经皮递送 |
| US20170246439A9 (en) | 2011-10-27 | 2017-08-31 | Kimberly-Clark Worldwide, Inc. | Increased Bioavailability of Transdermally Delivered Agents |
| US9931065B2 (en) * | 2012-04-04 | 2018-04-03 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
| EP2674184A1 (en) | 2012-06-15 | 2013-12-18 | Ares Trading S.A. | Injection device with needle sensor |
| EP2674179A1 (en) * | 2012-06-15 | 2013-12-18 | Ares Trading S.A. | Injection device |
| AU2014260023B2 (en) * | 2013-04-30 | 2018-12-06 | Abbott Diabetes Care Inc. | Systems, devices, and methods for energy efficient electrical device activation |
| US20160166777A1 (en) * | 2013-07-04 | 2016-06-16 | Insuline Medical Ltd. | Device, system and method for delivery of a long-acting drug |
| KR102290278B1 (ko) | 2014-08-12 | 2021-08-17 | 삼성전자주식회사 | 비침습 간기능 검사 장치 및 비침습 간기능 검사 방법 |
| WO2016196516A1 (en) | 2015-06-03 | 2016-12-08 | William Kenneth Ward | Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives |
| EP3804611B1 (en) | 2015-12-30 | 2024-07-17 | Dexcom, Inc. | Transcutaneous analyte sensor systems and methods |
| KR101868015B1 (ko) * | 2016-05-17 | 2018-06-15 | 주식회사 아이센스 | 인슐린 자동 공급장치 및 이를 이용한 당뇨 환자 관리 시스템 |
| EP3278728A1 (en) * | 2016-08-01 | 2018-02-07 | Nokia Technologies Oy | An apparatus, system and method for detecting analytes from a user's skin |
| JP2018063203A (ja) * | 2016-10-14 | 2018-04-19 | ソニーセミコンダクタソリューションズ株式会社 | 電位検出基板および電位計測装置 |
| US10863944B2 (en) | 2017-06-23 | 2020-12-15 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
| CA3077720A1 (en) | 2017-10-24 | 2019-05-02 | Dexcom, Inc. | Pre-connected analyte sensors |
| US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
| USD926325S1 (en) | 2018-06-22 | 2021-07-27 | Dexcom, Inc. | Wearable medical monitoring device |
| CN114269244A (zh) * | 2019-06-14 | 2022-04-01 | 太平洋糖尿病科技公司 | 用于连续葡萄糖监测的输注装置 |
| US20220211941A1 (en) * | 2019-07-19 | 2022-07-07 | Medtrum Technologies Inc. | Integrated drug infusion device |
| CN112237658B (zh) * | 2019-07-19 | 2022-10-04 | 上海移宇科技股份有限公司 | 集成型药物输注装置 |
| CN112237661B (zh) * | 2019-07-19 | 2022-10-11 | 上海移宇科技股份有限公司 | 输注检测于一体的单边驱动医疗装置 |
| US11523757B2 (en) * | 2019-08-01 | 2022-12-13 | Medtronic Minimed, Inc. | Micro-pillar working electrodes design to reduce backflow of hydrogen peroxide in glucose sensor |
| EP4017357A4 (en) * | 2019-08-19 | 2023-04-19 | Medtrum Technologies Inc. | DETECTION DEVICE |
| JP2023540905A (ja) * | 2020-08-23 | 2023-09-27 | パシフィック・ダイアビーツ・テクノロジーズ・インコーポレイテッド | インスリン保存剤の悪影響を最小限にすることによるインスリン送達カテーテル近傍でのグルコースの測定：代替配位子および酸化還元メディエーター金属 |
| US20240115799A1 (en) * | 2021-01-05 | 2024-04-11 | Medtrum Technologies Inc. | Skin patch drug infusion device |
| US20230145155A1 (en) * | 2021-10-29 | 2023-05-11 | Cercacor Laboratories, Inc. | Implantable micro-electrochemical cell |
| KR102674247B1 (ko) * | 2021-12-17 | 2024-06-12 | 이오플로우(주) | 약액 주입 장치 |
| WO2023168284A1 (en) * | 2022-03-01 | 2023-09-07 | Insulet Corporation | Single package automated drug delivery system |
| US20240306949A1 (en) * | 2022-12-23 | 2024-09-19 | Abbott Diabetes Care Inc. | Systems and methods for analyte monitoring |
| US20250127984A1 (en) * | 2023-10-20 | 2025-04-24 | Laxmi Therapeutic Devices, Inc. | Sensor cannula |
| CN119158115B (zh) * | 2024-10-29 | 2025-07-15 | 南通大学附属医院 | 一种使用效果好的治疗糖尿病的敷贴设备 |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2631847A (en) | 1949-04-19 | 1953-03-17 | Armstrong Cork Co | Web accumulator |
| US3631847A (en) * | 1966-03-04 | 1972-01-04 | James C Hobbs | Method and apparatus for injecting fluid into the vascular system |
| US3771694A (en) | 1972-07-07 | 1973-11-13 | A Kaminski | Infusion pump |
| US4403984A (en) * | 1979-12-28 | 1983-09-13 | Biotek, Inc. | System for demand-based adminstration of insulin |
| US4449843A (en) | 1981-11-30 | 1984-05-22 | Space Structures International Corp. | Octa hub |
| US4498843A (en) | 1982-08-02 | 1985-02-12 | Schneider Philip H | Insulin infusion pump |
| US4544369A (en) | 1983-11-22 | 1985-10-01 | C. R. Bard, Inc. | Battery operated miniature syringe infusion pump |
| US4657486A (en) | 1984-01-13 | 1987-04-14 | Stempfle Julius E | Portable infusion device |
| US4671288A (en) * | 1985-06-13 | 1987-06-09 | The Regents Of The University Of California | Electrochemical cell sensor for continuous short-term use in tissues and blood |
| US4685463A (en) * | 1986-04-03 | 1987-08-11 | Williams R Bruce | Device for continuous in vivo measurement of blood glucose concentrations |
| AT391998B (de) | 1987-02-02 | 1990-12-27 | Falko Dr Skrabal | Vorrichtung zur bestimmung der konzentration zumindest einer medizinischen substanz in lebenden organismen |
| US5390671A (en) * | 1994-03-15 | 1995-02-21 | Minimed Inc. | Transcutaneous sensor insertion set |
| IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| WO1997022291A1 (en) * | 1995-12-19 | 1997-06-26 | Abbott Laboratories | Device for the detection of analyte and administration of a therapeutic substance |
| US7267665B2 (en) * | 1999-06-03 | 2007-09-11 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
| WO1998058250A2 (en) * | 1997-06-16 | 1998-12-23 | Elan Corporation, Plc | Methods of calibrating and testing a sensor for in vivo measurement of an analyte and devices for use in such methods |
| US6033866A (en) * | 1997-12-08 | 2000-03-07 | Biomedix, Inc. | Highly sensitive amperometric bi-mediator-based glucose biosensor |
| US5957895A (en) | 1998-02-20 | 1999-09-28 | Becton Dickinson And Company | Low-profile automatic injection device with self-emptying reservoir |
| US5993423A (en) * | 1998-08-18 | 1999-11-30 | Choi; Soo Bong | Portable automatic syringe device and injection needle unit thereof |
| US6254586B1 (en) * | 1998-09-25 | 2001-07-03 | Minimed Inc. | Method and kit for supplying a fluid to a subcutaneous placement site |
| EP1413245B1 (en) * | 1998-10-08 | 2011-06-29 | Medtronic MiniMed, Inc. | Telemetered characteristic monitor system |
| EP1253852B1 (en) * | 2000-02-10 | 2007-09-19 | Medtronic MiniMed, Inc. | Analyte sensor |
| US6612111B1 (en) | 2000-03-27 | 2003-09-02 | Lifescan, Inc. | Method and device for sampling and analyzing interstitial fluid and whole blood samples |
| US6485461B1 (en) | 2000-04-04 | 2002-11-26 | Insulet, Inc. | Disposable infusion device |
| IT1314759B1 (it) * | 2000-05-08 | 2003-01-03 | Menarini Farma Ind | Strumentazione per la misura ed il controllo del contenuto di glucosiolattato o altri metaboliti in fluidi biologici |
| US6589229B1 (en) | 2000-07-31 | 2003-07-08 | Becton, Dickinson And Company | Wearable, self-contained drug infusion device |
| ES2287156T3 (es) | 2000-09-08 | 2007-12-16 | Insulet Corporation | Dispositivos y sistemas para la infusion de un paciente. |
| WO2002039086A2 (en) * | 2000-11-13 | 2002-05-16 | Nipro Diabetes Systems | Glucose sensor system |
| CN1185493C (zh) * | 2001-11-16 | 2005-01-19 | 清华大学 | 微损血糖测量方法及其装置 |
| US20050177398A1 (en) * | 2002-04-25 | 2005-08-11 | Motokazu Watanabe | Dosage determination supporting device, injector, and health management supporting system |
| US6723072B2 (en) | 2002-06-06 | 2004-04-20 | Insulet Corporation | Plunger assembly for patient infusion device |
| US20040010207A1 (en) * | 2002-07-15 | 2004-01-15 | Flaherty J. Christopher | Self-contained, automatic transcutaneous physiologic sensing system |
| US9414777B2 (en) * | 2004-07-13 | 2016-08-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US7547281B2 (en) * | 2005-02-01 | 2009-06-16 | Medtronic Minimed, Inc. | Algorithm sensor augmented bolus estimator for semi-closed loop infusion system |
| US20080269575A1 (en) * | 2005-02-17 | 2008-10-30 | Iddan Gavriel J | Method and Apparatus for Monitoring Bodily Analytes |
| CN101180093B (zh) * | 2005-03-21 | 2012-07-18 | 雅培糖尿病护理公司 | 用于提供结合的药剂输液以及分析物监测系统的方法和系统 |
| WO2006123329A2 (en) * | 2005-05-17 | 2006-11-23 | Medingo Ltd. | Disposable dispenser for patient infusion |
| US20060263839A1 (en) * | 2005-05-17 | 2006-11-23 | Isense Corporation | Combined drug delivery and analyte sensor apparatus |
| US7935104B2 (en) * | 2005-11-07 | 2011-05-03 | Medingo, Ltd. | Systems and methods for sustained medical infusion and devices related thereto |
| WO2007093981A2 (en) * | 2006-02-15 | 2007-08-23 | Medingo Ltd. | Systems and methods for sensing analyte and dispensing therapeutic fluid |
| US9119582B2 (en) * | 2006-06-30 | 2015-09-01 | Abbott Diabetes Care, Inc. | Integrated analyte sensor and infusion device and methods therefor |
| WO2008012817A1 (en) * | 2006-07-24 | 2008-01-31 | Medingo Ltd. | Systems, devices and methods for fluid/drug delivery |
| WO2008038274A1 (en) * | 2006-09-29 | 2008-04-03 | Medingo Ltd. | Fluid delivery system with electrochemical sensing of analyte concentration levels |
| DK2099384T3 (en) * | 2006-11-28 | 2018-10-08 | Hoffmann La Roche | IMPLEMENTATION DEVICE AND PROCEDURE FOR INTRODUCING A SUBCUTANT IMPORTANT ELEMENT IN A BODY |
| HUE065830T2 (hu) * | 2006-12-22 | 2024-06-28 | Hoffmann La Roche | Eszköz terápiás folyadék tartós bejuttatására |
-
2007
- 2007-12-20 WO PCT/IL2007/001579 patent/WO2008078319A1/en not_active Ceased
- 2007-12-20 EP EP07849605A patent/EP2124726A1/en not_active Withdrawn
- 2007-12-20 AU AU2007337685A patent/AU2007337685A1/en not_active Abandoned
- 2007-12-20 CN CN200780046642.3A patent/CN101563022B/zh not_active Expired - Fee Related
- 2007-12-20 EP EP13158027.6A patent/EP2601883A1/en not_active Withdrawn
- 2007-12-20 CN CN201210150258.0A patent/CN102743179B/zh not_active Expired - Fee Related
- 2007-12-20 JP JP2009542394A patent/JP5624322B2/ja not_active Expired - Fee Related
- 2007-12-21 US US11/963,481 patent/US9028409B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US9028409B2 (en) | 2015-05-12 |
| US20080214916A1 (en) | 2008-09-04 |
| CN102743179B (zh) | 2016-03-16 |
| WO2008078319A1 (en) | 2008-07-03 |
| CN102743179A (zh) | 2012-10-24 |
| EP2124726A1 (en) | 2009-12-02 |
| CN101563022B (zh) | 2012-05-30 |
| EP2601883A1 (en) | 2013-06-12 |
| CN101563022A (zh) | 2009-10-21 |
| AU2007337685A1 (en) | 2008-07-03 |
| JP2011507556A (ja) | 2011-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5624322B2 (ja) | 生体内電気化学的分析対象物感知を伴った液体供給 | |
| JP2011507556A5 (enExample) | ||
| CN101495179B (zh) | 药物递送和分析物传感器相结合的装置 | |
| US8814822B2 (en) | Reciprocating delivery of fluids to the body with analyte concentration monitoring | |
| KR100945901B1 (ko) | 어날라이트 농도를 모니터링하는 최소한의 침투 시스템과방법 | |
| US8603075B2 (en) | Fluid delivery system with electrochemical sensing of analyte concentration levels | |
| EP2224977B1 (en) | Analyte monitoring and fluid dispensing system | |
| DK2506914T3 (en) | ANALYSIS MONITORING AND FLUID SUBMISSION SYSTEM | |
| US20100268043A1 (en) | Device and Method for Preventing Diabetic Complications | |
| US20070191702A1 (en) | Systems and methods for sensing analyte and dispensing therapeutic fluid | |
| HK1189523A (en) | Combined drug delivery and analyte sensor apparatus | |
| HK1133217B (en) | Combined drug delivery and analyte sensor apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101215 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20101215 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120911 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120926 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20121218 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20121226 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130326 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131001 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131226 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140109 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20140116 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140326 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140829 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140926 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5624322 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |